Skip to main content

Table 4 Risk factors for malignancy in RS3PE by logistic models

From: bFGF could be a biomarker of malignancy in RS3PE syndrome: an ambispective single-center cohort analysis of 51 patients

Variables Univariate analysis Multivariate analysis
B OR (95%CI) P B OR (95%CI) P
Male 0.411 1.508 (0.317–7.177) 0.606    
Bilateral pitting edema of hands −2.61 0.074 (0.006–0.968) 0.047 −1.255 0.285 (0.035–2.320) 0.068
Good response to prednisolone −3.232 0.039 (0.005–0.311) 0.002 −1.967 0.140 (0.017–1.182) 0.071
bFGF>10ng/ml 2.651 14.084 (2.421–83.332) 0.003 2.686 14.667 (2.029–106.038) 0.008
  1. RS3PE remitting seronegative symmetrical synovitis with pitting edema, bFGF basic fibroblast growth factor